The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

Launched by NEGOVSKY REANIMATOLOGY RESEARCH INSTITUTE · Aug 3, 2022

Keywords

ClinConnect Summary

This clinical trial is studying two different pain management techniques for patients undergoing total knee replacement surgery. The focus is on comparing a single-shot adductor canal block (ACB) with a continuous femoral nerve block (FNB). Both methods aim to reduce pain after surgery, but the ACB is believed to have an advantage because it does not affect the ability to move the leg, which can help with recovery and reduce the risk of falls.

To participate in this trial, you need to be at least 18 years old and scheduled for a primary total knee replacement surgery. You should also be planning to receive neuraxial anesthesia (a type of regional anesthesia). However, if you have certain conditions, such as a known allergy to anesthetics or any infections near the injection sites, you may not be eligible. If you join the trial, you can expect to receive either the ACB or FNB technique and be monitored to see how well it helps with your pain and recovery. This study aims to provide valuable information that could improve pain management after knee surgery for many patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18
• • Planned primary total knee replacement
• • Planned neuraxial anesthesia
• • Written informed consent
• Exclusion Criteria:
• • Urgent surgery
• • Planned revision total knee replacement
• • Known allergic reaction to anesthetics
• • Confirmed localized infection at the puncture sites
• • Confirmed localized tumor at the puncture sites
• • Peripheral neuropathy of the lower extremities
• • Parkinson's disease
• • Previously enrolled in this trial